Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard F Little

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
The Journal of Infectious Diseases|May 7, 2010
Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphomaPeter D Burbelo, Alexandra T Issa, Kathryn H Ching, et al.
Blood|March 2, 2006
Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcomaRichard F Little, James M Pluda, Kathleen M Wyvill, et al.
Clinical Trials (London, England)|January 16, 2025
Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trialsAnna Moseley, Michael LeBlanc, Boris Freidlin, et al.
JAMA Network Open|December 1, 2020
Assessment of Cancer Therapy Evaluation Program Advocacy and Inclusion Rates of People Living With HIV in Anti-PD1/PDL1 Clinical TrialsJoshua E Reuss, Diana Stern, Jared C Foster, et al.
The Journal of Infectious Diseases|March 27, 2012
Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndromeAlex Ray, Vickie Marshall, Thomas Uldrick, et al.
Journal of the National Cancer Institute. Monographs|December 15, 2022
Integrating Geriatric Assessment Measures into National Cancer Institute Clinical TrialsAllison Magnuson, Noam Van der Walde, June M McKoy, et al.
Critical Reviews in Immunology|January 17, 2008
Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activityRobert Yarchoan, James M Pluda, Kathleen M Wyvill, et al.
Blood|February 5, 2010
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphomaKieron Dunleavy, Richard F Little, Stefania Pittaluga, et al.
Blood Cancer Journal|March 14, 2018
Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine eraRebecca L King, Grzegorz S Nowakowski, Thomas E Witzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working GroupThomas S Uldrick, Gwynn Ison, Michelle A Rudek, et al.
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
The Journal of Infectious Diseases|May 7, 2010
Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphomaPeter D Burbelo, Alexandra T Issa, Kathryn H Ching, et al.
Blood|March 2, 2006
Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcomaRichard F Little, James M Pluda, Kathleen M Wyvill, et al.
Clinical Trials (London, England)|January 16, 2025
Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trialsAnna Moseley, Michael LeBlanc, Boris Freidlin, et al.
JAMA Network Open|December 1, 2020
Assessment of Cancer Therapy Evaluation Program Advocacy and Inclusion Rates of People Living With HIV in Anti-PD1/PDL1 Clinical TrialsJoshua E Reuss, Diana Stern, Jared C Foster, et al.
The Journal of Infectious Diseases|March 27, 2012
Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndromeAlex Ray, Vickie Marshall, Thomas Uldrick, et al.
Journal of the National Cancer Institute. Monographs|December 15, 2022
Integrating Geriatric Assessment Measures into National Cancer Institute Clinical TrialsAllison Magnuson, Noam Van der Walde, June M McKoy, et al.
Critical Reviews in Immunology|January 17, 2008
Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activityRobert Yarchoan, James M Pluda, Kathleen M Wyvill, et al.
Blood|February 5, 2010
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphomaKieron Dunleavy, Richard F Little, Stefania Pittaluga, et al.
Blood Cancer Journal|March 14, 2018
Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine eraRebecca L King, Grzegorz S Nowakowski, Thomas E Witzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working GroupThomas S Uldrick, Gwynn Ison, Michelle A Rudek, et al.
Pageof 13